Healthcare provider profile · identity verified

Kyle G Van Dyke, MD

Family Practice · CHIPPEWA FALLS, WI · NPI 1245294800

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	132
Levothyroxine Sodium	Levothyroxine Sodium	300	77
Amlodipine Besylate	Amlodipine Besylate	259	78
Omeprazole	Omeprazole	257	74
Lisinopril	Lisinopril	242	78
Gabapentin	Gabapentin	201	47
Metformin Hcl Er	Metformin Hcl	156	42
Metoprolol Succinate	Metoprolol Succinate	148	45
Losartan Potassium	Losartan Potassium	147	44
Tamsulosin Hcl	Tamsulosin Hcl	147	33
Pantoprazole Sodium	Pantoprazole Sodium	137	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	27
Furosemide	Furosemide	134	35
Ozempic	Semaglutide	121	18
Trazodone Hcl	Trazodone Hcl	108	33
Metoprolol Tartrate	Metoprolol Tartrate	101	28
Simvastatin	Simvastatin	96	27
Hydrochlorothiazide	Hydrochlorothiazide	95	34
Tramadol Hcl	Tramadol Hcl	93	24
Rosuvastatin Calcium	Rosuvastatin Calcium	90	33
Pregabalin	Pregabalin	89	14
Sertraline Hcl	Sertraline Hcl	87	25
Fluoxetine Hcl	Fluoxetine Hcl	86	23
Albuterol Sulfate Hfa	Albuterol Sulfate	83	35
Metformin Hcl	Metformin Hcl	82	26
Prednisone	Prednisone	80	32
Mirtazapine	Mirtazapine	77	17
Paroxetine Hcl	Paroxetine Hcl	76	13
Clonazepam	Clonazepam	73	15
Warfarin Sodium	Warfarin Sodium	73	22
Tizanidine Hcl	Tizanidine Hcl	72	11
Carvedilol	Carvedilol	66	18
Bupropion Xl	Bupropion Hcl	64	13
Buspirone Hcl	Buspirone Hcl	63	12
Eliquis	Apixaban	63	17
Fluticasone Propionate	Fluticasone Propionate	62	28
Lorazepam	Lorazepam	62	13
Pravastatin Sodium	Pravastatin Sodium	59	16
Alprazolam	Alprazolam	56	13
Atenolol	Atenolol	56	18
Montelukast Sodium	Montelukast Sodium	54	14
Potassium Chloride	Potassium Chloride	54	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	52	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	52	11
Escitalopram Oxalate	Escitalopram Oxalate	50	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Jardiance	Empagliflozin	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	44	12
Clopidogrel	Clopidogrel Bisulfate	42	16
Triamcinolone Acetonide	Triamcinolone Acetonide	41	20
Oxycodone Hcl	Oxycodone Hcl	40	12
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Ventolin Hfa	Albuterol Sulfate	40	21
Trulicity	Dulaglutide	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	18
Primidone	Primidone	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Allopurinol	Allopurinol	34	suppressed
Famotidine	Famotidine	34	15
Amoxicillin	Amoxicillin	32	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Meloxicam	Meloxicam	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Glimepiride	Glimepiride	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Spironolactone	Spironolactone	25	suppressed
Carisoprodol	Carisoprodol	24	suppressed
Guanfacine Hcl	Guanfacine Hcl	24	suppressed
Fentanyl	Fentanyl	23	suppressed
Diazepam	Diazepam	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Cephalexin	Cephalexin	20	18
Chlorthalidone	Chlorthalidone	20	suppressed
Clotrimazole	Clotrimazole	20	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Azithromycin	Azithromycin	16	16
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Cefdinir	Cefdinir	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Torsemide	Torsemide	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Finasteride	Finasteride	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pen Needles	Pen Needle, Diabetic	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error